Phase 4 Depression and Anxiety Trial, Recruiting NCT06144177 Sponsor: Medical University of South Carolina Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 4 Depression and Anxiety Trial, Recruiting

NCT06144177
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The child is between 2 and 6 years old
  • The child is generally healthy or has only a mild health condition, as classified by anaesthesia guidelines (confirm with trial site)
  • The child is having a planned, non-emergency outpatient surgery (meaning they go home the same day)
  • The child will be receiving general anaesthesia for their procedure
  • A parent or guardian is willing to be present when anaesthesia is started

Who may not be able to join:

  • The child has had surgery before
  • The child has a fear of the dark
  • The child has a medical reason that makes it unsafe to use a mask to start their anaesthesia, such as an allergy to anaesthetic gases, not following fasting instructions before surgery, active nausea or vomiting, or severe acid reflux
  • The child has a severe developmental delay
  • The child is showing significant anxiety before the procedure
  • The child is currently taking any psychiatric medications
  • The child or family does not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Natalie Barnett, M.D., Medical University of South Carolina

Phone: 843-792-1869

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
16 April 2024
Est. completion
15 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mask acceptance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov